Fate Therapeutics, Inc.
2007-01-01
NASDAQ
United States of America
Cell programming and engineering of induced pluripotent stem cells (iPSCs)
Development of clonal master iPSC lines for cell therapy manufacturing
Off-the-shelf multiplexed-engineered T cell therapies
Off-the-shelf multiplexed-engineered natural killer (NK) cell therapies
Cell therapy product candidate development
Cell therapy development
Clinical drug candidate development for autoimmune diseases and cancer
iPSC platform-based cell product development
Off-the-shelf multiplexed-engineered cell product development
12278 Scripps Summit Drive San Diego, California 92131 United States
Bahram Valamehr
161 人
会社名
Group 親会社 子会社 得意先 仕入先 業務提携 銀行等 株主等

+ 開くと読み込みます
2026-08-07 01:38 (Model: ggml-org/gpt-oss-20b )
↑